According to Due Diligence Score, the 3 best medical distribution stocks to buy right now are:
1. Cencora (NYSE:COR)
Cencora (NYSE:COR) is the top medical distribution stock with a Due Diligence Score of 49, which is 16 points higher than the medical distribution industry average of 33. It passed 19 out of 38 due diligence checks and has strong fundamentals. Cencora has seen its stock return 26.08% over the past year, underperforming other medical distribution stocks by -1 percentage points.
Cencora has an average 1 year
price target of $276.00, an upside of 9.72% from Cencora's current stock price of $251.55.
Cencora stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Cencora, 37.5% have issued a Strong Buy rating, 37.5% have issued a Buy, 25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Patterson Companies (NASDAQ:PDCO)
Patterson Companies (NASDAQ:PDCO) is the second best medical distribution stock with a Due Diligence Score of 48, which is 15 points higher than the medical distribution industry average of 33. It passed 16 out of 38 due diligence checks and has strong fundamentals. Patterson Companies has seen its stock lose -17.38% over the past year, underperforming other medical distribution stocks by -44 percentage points.
Patterson Companies has an average 1 year
price target of $24.67, an upside of 14.78% from Patterson Companies's current stock price of $21.49.
Patterson Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Patterson Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Cardinal Health (NYSE:CAH)
Cardinal Health (NYSE:CAH) is the third best medical distribution stock with a Due Diligence Score of 46, which is 13 points higher than the medical distribution industry average of 33. It passed 16 out of 38 due diligence checks and has strong fundamentals. Cardinal Health has seen its stock return 16.09% over the past year, underperforming other medical distribution stocks by -11 percentage points.
Cardinal Health has an average 1 year
price target of $122.82, an upside of 0.47% from Cardinal Health's current stock price of $122.24.
Cardinal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Cardinal Health, 36.36% have issued a Strong Buy rating, 9.09% have issued a Buy, 45.45% have issued a hold, while 0% have issued a Sell rating, and 9.09% have issued a Strong Sell.